Quarter Financials
Teva Pharmaceutical Industries Limi... (TEVA)
$10.26
-0.12 (-1.16%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| Net Income | 56 | -232 | -955 | -159 | 292 | 207 | 77 | 150 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -11,660 | -11,716 | -11,484 | -10,529 | -10,370 | -10,662 | -10,869 | -10,946 |
|---|
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| Capital Expenditure | -122 | -127 | -157 | -153 | -146 | -113 | -150 | -176 |
|---|
| Net PPE | 5,990 | 6,181 | 6,396 | 6,477 | 6,547 | 6,658 | 6,641 | 6,854 |
|---|
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| New Purchases | - | - | - | - | -11 | -4 | - | 2 |
|---|
| Intangible and Goodwill | 20,624 | 20,302 | 20,421 | 20,179 | 20,040 | 19,986 | 18,837 | 18,433 |
|---|